ADAM12 is expressed by astrocytes during experimental demyelination

Brain Research

Volumn 1326, Issue , 2010, Pages 1-14

  Baertling, Fabian ^a   Kokozidou, Maria ^a   Pufe, Thomas ^a   Clarner, Tim ^a   Windoffer, Reinhard ^a   Wruck, Christoph J ^a   Brandenburg, Lars Ove ^a   Beyer, Cordian ^a   Kipp, Markus ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

ADAM12; Astrocyte; Cuprizone; Demyelination; Neuron; Oligodendrocyte

Indexed keywords

ADAM PROTEIN; CUPRIZONE; GLUTAMIC ACID; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN ADAM12; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; DEMYELINATION; IMMUNOFLUORESCENCE; MALE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADAM PROTEINS; ANIMALS; ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEUROFILAMENT PROTEINS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 77950027641     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.02.049     Document Type: Article

References (80)

1. Acs P., Kipp M., Norkute A., Johann S., Clarner T., Braun A., Berente Z., Komoly S., and Beyer C. 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 57 (2009) 807-814
2. Aktas O., Schulze-Topphoff U., and Zipp F. The role of TRAIL/TRAIL receptors in central nervous system pathology. Front Biosci. 12 (2007) 2912-2921
3. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., Ohmoto H., Node K., Yoshino K., Ishiguro H., Asanuma H., Sanada S., Matsumura Y., Takeda H., Beppu S., Tada M., Hori M., and Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8 (2002) 35-40
4. Barnett M.H., and Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55 (2004) 458-468
5. Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J. Parenter. Enteral Nutr. 30 (2006) 45-51
6. Bernstein H.G., Keilhoff G., Bukowska A., Ziegeler A., Funke S., Dobrowolny H., Kanakis D., Bogerts B., and Lendeckel U. ADAM (a disintegrin and metalloprotease) 12 is expressed in rat and human brain and localized to oligodendrocytes. J. Neurosci. Res. 75 (2004) 353-360
7. Bhat R.V., Axt K.J., Fosnaugh J.S., Smith K.J., Johnson K.A., Hill D.E., Kinzler K.W., and Baraban J.M. Expression of the APC tumor suppressor protein in oligodendroglia. Glia 17 (1996) 169-174
8. Brandenburg L.O. Kipp M. Lucius R. Pufe T. Wruck C.J. in press. Sulforaphane suppresses LPS-induced inflammation in primary rat microglia Inflamm. Res.
9. Braun A., Dang J., Johann S., Beyer C., and Kipp M. Selective regulation of growth factor expression in cultured cortical astrocytes by neuro-pathological toxins. Neurochem. Int. 55 (2009) 610-618
10. Cantarella C., Cayre M., Magalon K., and Durbec P. Intranasal HB-EGF administration favors adult SVZ cell mobilization to demyelinated lesions in mouse corpus callosum. Dev. Neurobiol. 68 (2008) 223-236
11. Chiba Y., Onoda S., Hattori Y., Maitani Y., Sakai H., and Misawa M. Upregulation of ADAM8 in the airways of mice with allergic bronchial asthma. Lung 187 (2009) 179-185
12. Cowans N.J., and Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat. Diagn. 27 (2007) 264-271
13. D'Ercole A.J., Ye P., Calikoglu A.S., and Gutierrez-Ospina G. The role of the insulin-like growth factors in the central nervous system. Mol. Neurobiol. 13 (1996) 227-255
14. Emerson M.R., Biswas S., and LeVine S.M. Cuprizone and piperonyl butoxide, proposed inhibitors of T-cell function, attenuate experimental allergic encephalomyelitis in SJL mice. J. Neuroimmunol. 119 (2001) 205-213
15. Estrella C., Rocks N., Paulissen G., Quesada-Calvo F., Noel A., Vilain E., Lassalle P., Tillie-Leblond I., Cataldo D., and Gosset P. Role of A disintegrin and metalloprotease-12 in neutrophil recruitment induced by airway epithelium. Am. J. Respir. Cell Mol. Biol. 41 (2009) 449-458
16. Fambrough D., Pan D., Rubin G.M., and Goodman C.S. The cell surface metalloprotease/disintegrin Kuzbanian is required for axonal extension in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 13233-13238
17. Garcia-Segura L.M., Duenas M., Fernandez-Galaz M.C., Chowen J.A., Argente J., Naftolin F., and Torres-Aleman I. Interaction of the signalling pathways of insulin-like growth factor-I and sex steroids in the neuroendocrine hypothalamus. Horm. Res. 46 (1996) 160-164
18. Gilpin B.J., Loechel F., Mattei M.G., Engvall E., Albrechtsen R., and Wewer U.M. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J. Biol. Chem. 273 (1998) 157-166
19. Goldbaum O., Jensen P.H., and Richter-Landsberg C. The expression of tubulin polymerization promoting protein TPPP/p25alpha is developmentally regulated in cultured rat brain oligodendrocytes and affected by proteolytic stress. Glia 56 (2008) 1736-1746
20. Gosselin D., and Rivest S. Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system. Brain Behav. Immun. 21 (2007) 281-289
21. Groebe A., Clarner T., Baumgartner W., Dang J., Beyer C., and Kipp M. Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum. Cerebellum 8 (2009) 163-174
22. Harold D., Jehu L., Turic D., Hollingworth P., Moore P., Summerhayes P., Moskvina V., Foy C., Archer N., Hamilton B.A., Lovestone S., Powell J., Brayne C., Rubinsztein D.C., Jones L., O'Donovan M.C., Owen M.J., and Williams J. Interaction between the ADAM12 and SH3MD1 genes may confer susceptibility to late-onset Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B (2007) 448-452
23. Henry C.J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M.T., Sheridan J.F., and Godbout J.P. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J. Neuroinflammation 5 (2008) 15
24. Honda M., Eriksson K.S., Zhang S., Tanaka S., Lin L., Salehi A., Hesla P.E., Maehlen J., Gaus S.E., Yanagisawa M., Sakurai T., Taheri S., Tsuchiya K., Honda Y., and Mignot E. IGFBP3 colocalizes with and regulates hypocretin (orexin). PLoS ONE 4 (2009) e4254
25. Horvat S., Beyer C., and Arnold S. Effect of hypoxia on the transcription pattern of subunit isoforms and the kinetics of cytochrome c oxidase in cortical astrocytes and cerebellar neurons. J. Neurochem. 99 (2006) 937-951
26. Huang Y., Erdmann N., Peng H., Zhao Y., and Zheng J. The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases. Cell. Mol. Immunol. 2 (2005) 113-122
27. Ivanova T., and Beyer C. Estrogen regulates tyrosine hydroxylase expression in the neonate mouse midbrain. J. Neurobiol. 54 (2003) 638-647
28. Iwadate H., Sugisaki T., Kudo M., and Kizuki K. Actions of insulin-like growth factor binding protein-5 (IGFBP-5) are potentially regulated by tissue kallikrein in rat brains. Life Sci. 73 (2003) 3149-3158
29. Jacobsen J., and Wewer U.M. Targeting ADAM12 in human disease: head, body or tail?. Curr. Pharm. Des. 15 (2009) 2300-2310
30. Johann S., Kampmann E., Denecke B., Arnold S., Kipp M., Mey J., and Beyer C. Expression of enzymes involved in the prostanoid metabolism by cortical astrocytes after LPS-induced inflammation. J. Mol. Neurosci. 34 (2008) 177-185
31. Kajta M., Trotter A., Lason W., and Beyer C. Impact of 17beta-estradiol on cytokine-mediated apoptotic effects in primary hippocampal and neocortical cell cultures. Brain Res. 1116 (2006) 64-74
32. Karakaya S., Kipp M., and Beyer C. Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system. J. Neuroendocrinol. 19 (2007) 682-690
33. Kipp M., Karakaya S., Johann S., Kampmann E., Mey J., and Beyer C. Oestrogen and progesterone reduce lipopolysaccharide-induced expression of tumour necrosis factor-alpha and interleukin-18 in midbrain astrocytes. J. Neuroendocrinol. 19 (2007) 819-822
34. Kipp M., Norkute A., Johann S., Lorenz L., Braun A., Hieble A., Gingele S., Pott F., Richter J., and Beyer C. Brain-region-specific astroglial responses in vitro after LPS exposure. J. Mol. Neurosci. 35 (2008) 235-243
35. Kipp M., Clarner T., Dang J., Copray S., and Beyer C. The cuprizone animal model: new insights into an old story. Acta Neuropathol. 118 (2009) 723-736
36. Kodama T., Ikeda E., Okada A., Ohtsuka T., Shimoda M., Shiomi T., Yoshida K., Nakada M., Ohuchi E., and Okada Y. ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor. Am. J. Pathol. 165 (2004) 1743-1753
37. Komoly S., Hudson L.D., Webster H.D., and Bondy C.A. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 1894-1898
38. Kornblum H.I., Zurcher S.D., Werb Z., Derynck R., and Seroogy K.B. Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system. Eur. J. NeuroSci. 11 (1999) 3236-3246
39. Kramer, M., Dang, J., Baertling, F., Denecke, B., Clarner, T., Kirsch, C., Beyer, C., Kipp, M., 2010. TTC staining of damaged brain areas after MCA occlusion in the rat does not constrict quantitative gene and protein analyses. J Neurosci Methods. 187, 84-89.
40. Kveiborg M., Albrechtsen R., Rudkjaer L., Wen G., Damgaard-Pedersen K., and Wewer U.M. ADAM12-S stimulates bone growth in transgenic mice by modulating chondrocyte proliferation and maturation. J. Bone Miner. Res. 21 (2006) 1288-1296
41. Kveiborg M., Albrechtsen R., Couchman J.R., and Wewer U.M. Cellular roles of ADAM12 in health and disease. Int. J. Biochem. Cell Biol. 40 (2008) 1685-1702
42. Lassmann H. Models of multiple sclerosis: new insights into pathophysiology and repair. Curr. Opin. Neurol. 21 (2008) 242-247
43. Lee H.N., Jeon G.S., Kim D.W., Cho I.H., and Cho S.S. Expression of adenomatous polyposis coli protein in reactive astrocytes in hippocampus of kainic acid-induced rat. Neurochem. Res. 35 (2009) 114-121
44. Lin J., Luo J., and Redies C. Differential expression of five members of the ADAM family in the developing chicken brain. Neuroscience 157 (2008) 360-375
45. Loechel F., Fox J.W., Murphy G., Albrechtsen R., and Wewer U.M. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem. Biophys. Res. Commun. 278 (2000) 511-515
46. Mahoney E.T., Benton R.L., Maddie M.A., Whittemore S.R., and Hagg T. ADAM8 is selectively up-regulated in endothelial cells and is associated with angiogenesis after spinal cord injury in adult mice. J. Comp. Neurol. 512 (2009) 243-255
47. Malinin N.L., Wright S., Seubert P., Schenk D., and Griswold-Prenner I. Amyloid-beta neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activity. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3058-3063
48. Mana P., Fordham S.A., Staykova M.A., Correcha M., Silva D., Willenborg D.O., and Linares D. Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation. J. Neuroimmunol. 210 (2009) 13-21
49. Mason J.L., Ye P., Suzuki K., D'Ercole A.J., and Matsushima G.K. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J. Neurosci. 20 (2000) 5703-5708
50. Mason J.L., Xuan S., Dragatsis I., Efstratiadis A., and Goldman J.E. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J. Neurosci. 23 (2003) 7710-7718
51. Matsushima G.K., and Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11 (2001) 107-116
52. Mela A., and Goldman J.E. The tetraspanin KAI1/CD82 is expressed by late-lineage oligodendrocyte precursors and may function to restrict precursor migration and promote oligodendrocyte differentiation and myelination. J. Neurosci. 29 (2009) 11172-11181
53. Mochizuki S., and Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci. 98 (2007) 621-628
54. Morell P., Barrett C.V., Mason J.L., Toews A.D., Hostettler J.D., Knapp G.W., and Matsushima G.K. Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol. Cell. Neurosci. 12 (1998) 220-227
55. Moss M.L., Bomar M., Liu Q., Sage H., Dempsey P., Lenhart P.M., Gillispie P.A., Stoeck A., Wildeboer D., Bartsch J.W., Palmisano R., and Zhou P. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J. Biol. Chem. 282 (2007) 35712-35721
56. Mukherjee A., Wilson E.M., and Rotwein P. Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions. Mol. Endocrinol. 22 (2008) 206-215
57. Najy A.J., Day K.C., and Day M.L. ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction. Cancer Res. 68 (2008) 1092-1099
58. Nishi E., and Klagsbrun M. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a mediator of multiple physiological and pathological pathways. Growth Factors 22 (2004) 253-260
59. Norkute A., Hieble A., Braun A., Johann S., Clarner T., Baumgartner W., Beyer C., and Kipp M. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus. J. Neurosci. Res. 87 (2009) 1343-1355
60. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343 (2000) 938-952
61. O'Reilly T., Ostergaard C., Vaxelaire J., and Zak O. Systemic inflammation alters the inflammatory response in experimental lipopolysaccharide-induced meningitis. Clin. Exp. Immunol. 147 (2007) 112-119
62. Palsson-McDermott E.M., and O'Neill L.A. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113 (2004) 153-162
63. Pan D., and Rubin G.M. Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90 (1997) 271-280
64. Pasten-Hidalgo K., Hernandez-Rivas R., Roa-Espitia A.L., Sanchez-Gutierrez M., Martinez-Perez F., Monrroy A.O., Hernandez-Gonzalez E.O., and Mujica A. Presence, processing, and localization of mouse ADAM15 during sperm maturation and the role of its disintegrin domain during sperm-egg binding. Reproduction 136 (2008) 41-51
65. Pawlak J., Karolczak M., Krust A., Chambon P., and Beyer C. Estrogen receptor-alpha is associated with the plasma membrane of astrocytes and coupled to the MAP/Src-kinase pathway. Glia 50 (2005) 270-275
66. Pitt D., Nagelmeier I.E., Wilson H.C., and Raine C.S. Glutamate uptake by oligodendrocytes: implications for excitotoxicity in multiple sclerosis. Neurology 61 (2003) 1113-1120
67. Pott F., Gingele S., Clarner T., Dang J., Baumgartner W., Beyer C., and Kipp M. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia. Brain Res. 1305 (2009) 137-149
68. Rechler M.M., and Clemmons D.R. Regulatory Actions of Insulin-like Growth Factor-binding Proteins. Trends Endocrinol. Metab. 9 (1998) 176-183
69. Richter-Landsberg C., and Heinrich M. OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J. Neurosci. Res. 45 (1996) 161-173
70. Tanabe C., Hotoda N., Sasagawa N., Sehara-Fujisawa A., Maruyama K., and Ishiura S. ADAM19 is tightly associated with constitutive Alzheimer's disease APP alpha-secretase in A172 cells. Biochem. Biophys. Res. Commun. 352 (2007) 111-117
71. Thangapazham R.L., Sharma A., and Maheshwari R.K. Multiple molecular targets in cancer chemoprevention by curcumin. Aaps J. 8 (2006) E443-E449
72. Toft-Hansen H., Nuttall R.K., Edwards D.R., and Owens T. Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J. Immunol. 173 (2004) 5209-5218
73. Ulfig N., Nickel J., and Bohl J. Monoclonal antibodies SMI 311 and SMI 312 as tools to investigate the maturation of nerve cells and axonal patterns in human fetal brain. Cell Tissue Res. 291 (1998) 433-443
74. Valdes A.M., Hart D.J., Jones K.A., Surdulescu G., Swarbrick P., Doyle D.V., Schafer A.J., and Spector T.D. Association study of candidate genes for the prevalence and progression of knee osteoarthritis. Arthritis Rheum. 50 (2004) 2497-2507
75. Watt B.E., Proudfoot A.T., and Vale J.A. Hydrogen peroxide poisoning. Toxicol. Rev. 23 (2004) 51-57
76. Werner P., Pitt D., and Raine C.S. Glutamate excitotoxicity-a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?. J. Neural Transm. (2000) 375-385 Suppl
77. Williams A., Piaton G., and Lubetzki C. Astrocytes-friends or foes in multiple sclerosis?. Glia 55 (2007) 1300-1312
78. Wolfsberg T.G., Straight P.D., Gerena R.L., Huovila A.P., Primakoff P., Myles D.G., and White J.M. ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev. Biol. 169 (1995) 378-383
79. Yagami-Hiromasa T., Sato T., Kurisaki T., Kamijo K., Nabeshima Y., and Fujisawa-Sehara A. A metalloprotease-disintegrin participating in myoblast fusion. Nature 377 (1995) 652-656
80. Ye P., Kollias G., and D'Ercole A.J. Insulin-like growth factor-I ameliorates demyelination induced by tumor necrosis factor-alpha in transgenic mice. J. Neurosci. Res. 85 (2007) 712-722